Acute Porphyria Drug Database

Monograph

H01CC01 - Ganirelix
Propably not porphyrinogenic
PNP

Rationale
Peptide, hormone antagonist interacting with sex hormone production.
Chemical description
GnRH-antagonist (peptide). Used in assisted fertilisation for prevention of a premature LH-increase.
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes H01C / H01CC or go back.
Tradenames
This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.


Fyremadel · Ganirelix · Orgalutran Fyremadel · Ganirelix · Orgalutran · Ovamex Astarte · Fyremadel · Ganirelix · Orgalutran Ganirelix · Orgalutran Fyremadel · Ganirelix · Orgalutran · Ovamex Fyremadel · Ganirelix · Orgalutran Fyremadel · Ganirelix Fyremadel · Ganirelix · Orgalutran · Ovamex Ganirelix · Orgalutran Ganirelix · Orgalutran Fyremadel · Ganirelix · Orgalutran Ganirelix · Orgalutran Ganirelix · Orgalutran
 
© NAPOS 2025
An unhandled error has occurred. Reload 🗙